能够自愿调节甲基频段活动的能力影响了药理学操纵 катехоламинергия系统对认知控制的影响
Astrid Prochnow1,2, Moritz Mückschel1,2, Elena Eggert1,2
1Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
The international journal of neuropsychopharmacology
|January 5, 2024
概括
个体的大脑波活动 (甲基酸波段调制) 影响了像甲基酸这样的兴奋剂药物对反应抑制的影响. 这凸显了自我调节能力在认知控制中的重要性.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 心理药理学 心理药理学
背景情况:
- 在反应抑制中, катехоламинергия系统的作用是可变的.
- 测得频段活动的自愿调制可能解释了阻断反应的个体差异.
- 了解这种变异性对于有效的认知控制干预至关重要.
研究的目的:
- 为了研究在多大程度上对答应抑制的甲基胺效应的个体差异取决于自愿的达频段活性调制.
- 探索甲基化物,甲基频段活性和反应抑制之间的相互作用.
- 为了确定大脑振荡的自我调节是否会影响对认知控制的药物效应.
主要方法:
- 67名健康成年人参与了一项随机,双盲,交叉研究.
- 参与者接受了甲基化物或安慰剂,并执行了Go/Nogo任务.
- 分析了EEG数据,以评估甲基频段活性调制及其与药物影响的相互作用.
主要成果:
- 甲基化物效应和甲基频段调制对错误报警率有显著的相互作用.
- 多变量模式分析表明了刺激处理和响应选择水平上的相互作用.
- 个体的太波段可调节性影响了甲基胺对认知控制的影响.
结论:
- 个体的甲波段调节性会影响 катехоламинергия系统对药理学药物的反应.
- 操纵神经系统进行认知控制的有效性取决于个体自我调节大脑振荡的能力.
- 这些发现表明,认知增强和治疗的个性化方法.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
127
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
127
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


